News Releases | RxFunction

October 7, 2022

walk2Wellness study results published in Frontiers in Aging Neuroscience suggest Walkasins wearable sensory prosthesis improves gait and balance and may reduce falls for people with peripheral neuropathy

October 30, 2020

Walk2Wellness Study Publication Demonstrates Wearable Medical Device Improves Gait and Balance in Patients at High Fall Risk

August 29, 2020

RxFunction Awarded Department of Defense Contract for Project

July 16, 2020

RxFunction Presents at Two Virtual Scientific Neurology Conferences

March 9, 2020

Johns Hopkins School of Medicine, Baltimore, Maryland added as 5th walk2Wellness Clinical Study Site

walk2Wellness-adds-5th-site

March 3, 2020

Lars Oddsson Presents March 6th at ISPRM 2020

November 5, 2019

walk2Wellness Clinical Data Presented at ACRM 2019

October 28, 2019

RxFunction Expands IP with Patent Issued August 2019

October 23, 2019

Hebrew SeniorLife Added to walk2Wellness Clinical Trial

August 30, 2019

Walkasins® clinical research published April 30, 2019 in PLOS ONE. Shows short-term use of device lowers fall-risk for peripheral neuropathy patients.